DERMABOND ADVANCED® Topical Skin Adhesive

DERMABOND ADVANCED Adhesive is a wound closure device that adds strength when used in conjunction with deep dermal stitches after strength, provides a protective barrier1,2 and demonstrated in vitro inhibits bacteria.3

Adhesivo Tópico Para La Piel DERMABOND®

Features & Benefits

  • DERMABOND ADVANCED® Topical Skin Adhesive Card 1

    Additional Strength for Secure Closure

    When used in addition to sutures, DERMABOND ADVANCED Adhesive was shown ex vivo to add 75% more strength to wound closure than sutures alone.4

  • DERMABOND ADVANCED® Topical Skin Adhesive Card 2

    Microbial Barrier Protection5
     

    DERMABOND ADVANCED Adhesive provides a microbial barrier with 99% protection in vitro for at least 72 hours against organisms commonly responsible for surgical site infections (SSIs)5**

  • DERMABOND ADVANCED® Topical Skin Adhesive Card 3

    Extensive Clinical Evidence

    DERMABOND Advanced Adhesive is supported by substantially more Randomized Controlled Trials (RCTs) than the top six competitors combined6-8,*†‡


     

Product Specifications

Product Code

Product Code

Description

 
DNX12 DNX12 DERMABOND ADVANCED TOPICAL SKIN ADHESIVE - UNIQUE FORMULATION WITH AN EASY-TO-USE APPLICATOR FOR PRECISE CONTROL FOR WIDE AND FINE LINE APPLICATIONS; 0.7ML ADHESIVE VOLUME 

Product Code

Product Code

Description

 
DNX6 DNX6 DERMABOND ADVANCED TOPICAL SKIN ADHESIVE - UNIQUE FORMULATION WITH AN EASY-TO-USE APPLICATOR FOR PRECISE CONTROL FOR WIDE AND FINE LINE APPLICATIONS; 0.7ML ADHESIVE VOLUME 

Product Resources

Resources

DERMABOND ADVANCED Topical Skin Adhesive Application Video

Supporting Documentation

Clinical Evidence

DERMABOND ADVANCED Adhesive Clinical Evidence Summary

Product Support

DERMABOND ADVANCED® Topical Skin Adhesive Brochure

DERMABOND ADVANCED® Topical Skin Adhesive Patient Care Instruction Pad

DERMABOND ADVANCED® Topical Skin Adhesive Proof vs. Perception

Understanding the Health Care Landscape: The Affordable Care Act

DERMABOND ADVANCED® Topical Skin Adhesive vs. Advanced Medical Solutions Cardinal Health Liquidband OCTYL Topical Skin Adhesive

References

**Staphylococcus epidermidis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecium.

*DERMABOND ADVANCED Adhesive tests equivalent or superior to DERMABOND Adhesive in head-to-head testing for microbial barrier, wound-bursting strength, tensile strength, flexibility, durability, viscosity, drying time, water vapor transmission rate, water resistance, and physician satisfaction.

†Based on published literature in PubMed as of March 7, 2017, using only RCTs that evaluated the use of the product in a manner consistent with intended indication.

‡Top 6 US competitors include LiquiBand®, Skin Aix™, SwiftSet™, SurgiSeal®, Derma+Flex® QS™, and Histoacryl®.

 1. Quinn J, Wells G, Sutcliffe T, et al. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA. 1997;277(19):1527-1530.

2. Singer AJ, Perry LC, Allen RL. In vivo study of wound-bursting strength and compliance of topical skin adhesives. Acad Emerg Med. 2008;15(12):1290-1294.

3. Bhende S, Rothenburger S, Spangler DJ, Dito M. In vitro assessment of microbial barrier properties of DERMABOND® Topical Skin Adhesive. Surg Infect (Larchmt). 2002;3(3):251-257.

4. Report: Protocol to determine the strength benefits when adding DERMABOND™ ADVANCED Topical Skin Adhesive to a wound or incision using suture as the primary closure.

5. Bhende S, Rothenburger S, Spangler DJ, Dito M. In vitro assessment of microbial barrier properties of DERMABOND® Topical Skin Adhesive.Surg Infect (Larchmt).2002;3(3):251-257.

6. Ethicon US Market Share Report, October 2016.

7. Dermabond RCT List, Jan 2017.

8. Competitive TSA RCT Summary.

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.